Compounds > hamamelose
Page last updated: 2024-12-08

hamamelose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hamamelose: common sugar of green land plants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193393
CHEBI ID18004
SCHEMBL ID5496629
MeSH IDM0054728

Synonyms (14)

Synonym
2-c-(hydroxymethyl)-d-ribose
CHEBI:18004 ,
hamamelose
(2r,3r,4r)-2,3,4,5-tetrahydroxy-2-(hydroxymethyl)pentanal
3107imr9fu ,
unii-3107imr9fu
SCHEMBL5496629
469-33-0
hamamelose [mi]
d-ribose, 2-c-(hydroxymethyl)-
hamamelose d-form [mi]
Q27102754
CS-0226130
HY-W145688

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aldopentoseA pentose with a (potential) aldehyde group at one end.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.38 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
gallic acid
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.		2.610trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
propylene
propylene: structure		2.610alkene;
gas molecular entity		refrigerant;
xenobiotic
galactose
aldohexose : A hexose with a (potential) aldehyde group at one end.		3.0950
2-carboxyarabinitol 1-phosphate
2-carboxyarabinitol 1-phosphate: nocturnal inhibitor		2.420ribonic acid phosphate
D-fructopyranose
[no description available]		1.9510cyclic hemiketal;
D-fructose;
fructopyranose		sweetening agent
ribose
ribopyranose : The pyranose form of ribose.		2.3820D-ribose;
ribopyranose
hamamelitannin
hamamelitannin: cytotoxic from witch hazel (Hamamelis virginiana); structure in first source		7.610gallate ester
fructose-1,6-diphosphate
fructose-1,6-diphosphate: RN refers to (D)-isomer		2.0110
ConditionIndicatedRelationship StrengthStudiesTrials